Eumunity

Eumunity is a precision immunology company that leverages a proprietary platform to measure and monitor the state of the human immune system. By analyzing gene expression patterns, specifically a "common response" signature identified through research at Stanford University, the company provides insights into an individual's immune health and resilience. Their technology aims to enable early detection of infections, predict vaccine responses, and monitor chronic inflammatory conditions. Eumunity's mission is to transform healthcare from a reactive model to a proactive, personalized approach based on real-time immune system data. The company is currently developing diagnostic tools to bring this "immune clock" technology to clinical and consumer markets.